#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangiosarcoma Breast cancer metastatic Erythema multiforme Diffuse large B-cell lymphoma refractory Narcolepsy Pancreatic carcinoma PIK3CA-activated mutation Optic ischaemic neuropathy Endometrial adenocarcinoma Marginal zone lymphoma refractory Choroidal dystrophy Hepatitis B Osteosarcoma recurrent Immune-mediated renal disorder Immunoglobulin G4 related disease More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Diagnostics Stevens-Johnson syndrome – Basic Information Indolent systemic mastocytosis Sarcoidosis – Diagnostics Mucopolysaccharidosis III – Trials in Disease Richter’s syndrome – Life with Disease Hereditary ataxia – Trials in Disease Krabbe’s disease – Diagnostics Rosai-Dorfman syndrome – Trials in Disease Biotinidase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fosaprepitant Tucidinostat Daunorubicin Hydrochloride VANDETANIB Prednisolone Rbl005.3 Elivaldogene Autotemcel Avelumab Promethazine Hydrochloride [18F]Alf-Nota-Octreotide Afatinib Namodenoson VOTOPLAM Omp11 Eye103 Imipenem Anhydrate RNMB1 Denosumab Thiopental Sodium Aavanc80-3'Hotof More therapies…

    Learn about Your Condition

    Procedural pain Cholecystitis acute Cardiac valve disease Hidradenitis Abdominal pain Nasopharyngeal cancer Tachypnoea Vulvovaginal pruritus Uterine leiomyosarcoma Clostridium difficile colitis Basal cell naevus syndrome Dengue fever Gastric cancer Herpes virus infection Guttate psoriasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. KBC Zagreb

KBC Zagreb

Ulica Mije Kispatica 12, Zagreb, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Crizotinib
    • Entrectinib
    Croatia France Germany Greece Italy The Netherlands +4

  • Study on the Effects of Semaglutide in Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study on the Safety of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Croatia Cyprus Greece Spain

  • Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    Austria Belgium Bulgaria Croatia France Germany +5

  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Valbenazine Ditosylate
    Bulgaria Croatia Czechia Romania Slovakia Spain

  • Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    • Salbutamol Sulfate Ph. Eur.
    • Budesonide
    Austria Croatia Czechia France Germany Hungary +3

  • Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

    Not recruiting

    3 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +7

  • Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Rosnilimab
    Austria Bulgaria Croatia France Germany Italy +4

  • Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epcoritamab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Rezpegaldesleukin
    Bulgaria Croatia Czechia Germany Hungary Poland +1
Previous Page
1 … 10 11 12 13 14 … 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!